Breaking News

Personalised and digitised: the future of pharma

Dr Kevin Robinson recently caught up with ChargePoint’s Ben Wylie and Cognizant’s Trevor Marshall to find out what trends and innovations the pharm...

AMSBIO highlights groundbreaking 2023 life science research

In an informative new blog post, AMSBIO reflects on a selection of the groundbreaking life science and biomedical research undertaken by its custom...

EC appoints RISE Research Institutes as a reference laboratory for medical devices for in vitro diagnostics

RISE is one of two laboratories in Europe appointed to evaluate products for in vitro diagnostics to diagnose virus-borne upper respiratory tract i...

Getting personal: a patient-centred approach to rare disease drug development

In this article, Nazim Kanji, Executive Director, Pediatric Services at Quotient Sciences, explores the challenges associated with developing formu...

Gyros Protein Technologies and Biotage partner to advance peptide purification efficiency

Partnership complements Gyros’ PurePep EasyClean technology offering with an automated solution for advanced discovery process

Enhanced protection to manufacture highly potent pharmaceuticals introduced at NJ facility

Experic, a contract development and manufacturing organization (CDMO) and clinical trial supply services company serving the biopharmaceutical indu...

Driving peptide development and manufacturing

Peptides are revolutionising drug discovery and development. Sitting in size between the classic small molecule drugs (SMDs) and the newer generati...

How to proactively address EU HTAR implementation challenges before 2025

Data landscape challenges within the European Union (EU) have historically been driven by the different laws, processes and regulatory standards of...

Aptar Pharma continues global expansion with new Mumbai site

Aptar Mumbai to increase manufacturing capabilities in growing South East Asia market

Innovent Biologics and Synaffix expand ADC collaboration

New deal builds on encouraging preliminary clinical data from the Phase I study of the first antibody-drug conjugate (ADC) developed under the agre...

The roadmap to success in the cannabinoid drug development journey

The key to success in the development and registration of cannabinoid-based medicines hinges on choosing a GMP-certified high-purity active ingredi...

Adding more to the cell and gene therapy playbook

With notable advances in various forms of administration, including making the use of viral vectors safer, non-viral delivery with lipid nanopartic...

TeraPore launches IsoBlock VF viral filtration products with proprietary membrane technology

TeraPore Technologies, an innovator in nanofiltration membranes, has commercially launched the flagship IsoBlock VF product line for parvovirus rem...

Diagnosing hormone-based disorders using saliva

Diagnosing hormone-based disorders using saliva samples dates back to the 1980s; however, it’s only the sensitivity improvements that have occurred...

Abzena Partners with ProteoNic to offer enhanced CHO cell line platform for complex biologics

Premium vector technology will improve the production of high-yielding mammalian cell lines

The right validation model: practical considerations and applications

It is widely accepted that validation in the life sciences industry follows a lifecycle model (1,2). What is not always clear is the specific model...

Most Popular

  1. Driving peptide development and manufacturing
  2. Getting personal: a patient-centred approach to rare disease drug development
  3. New state-of-the-art genomic services facility opening in the UK
  4. Hello SDAX! SCHOTT Pharma reaches next milestone as a publicly listed company
  5. Vetter joins Science Based Targets initiative

Inspiration and Learning

Manufacturing Chemist Stand Side with IMA S.p.A
Manufacturing Chemist Stand Side with IMA S.p.A
Manufacturing Chemist Stand Side with ACG
Manufacturing Chemist Stand Side with ACG
Manufacturing Chemist Stand Side with Lonza
Manufacturing Chemist Stand Side with Lonza
Manufacturing Chemist Stand Side with Piramal Pharma Solutions
Manufacturing Chemist Stand Side with Piramal Pharma Solutions
Manufacturing Chemist Stand Side with Syntegon
Manufacturing Chemist Stand Side with Syntegon
Manufacturing Chemist Stand Side with C2 Pharma
Manufacturing Chemist Stand Side with C2 Pharma
Manufacturing Chemist Stand Side with Almac
Manufacturing Chemist Stand Side with Almac
Enteric delivery of my API: how to make it right?
Enteric delivery of my API: how to make it right?
Find the right diaphragm valve for pharmaceutical applications - DOWNLOAD THE NEW REPORT
Find the right diaphragm valve for pharmaceutical applications - DOWNLOAD THE NEW REPORT
Cleaning validation and verification in a high potent granulation suite
Cleaning validation and verification in a high potent granulation suite

Careers

Reports

Getting personal: a patient-centred approach to rare disease drug development
Getting personal: a patient-centred approach to rare disease drug development
Driving peptide development and manufacturing
Driving peptide development and manufacturing
The roadmap to success in the cannabinoid drug development journey
The roadmap to success in the cannabinoid drug development journey
Diagnosing hormone-based disorders using saliva
Diagnosing hormone-based disorders using saliva
The right validation model: practical considerations and applications
The right validation model: practical considerations and applications
Analytical method development in a high potent facility
Analytical method development in a high potent facility
Investing in a manufacturing infrastructure to harness tumour-infiltrating lymphocytes (TILs) for cancer treatment
Investing in a manufacturing infrastructure to harness tumour-infiltrating lymphocytes (TILs) for cancer treatment
Simplifying technology transfer to get drugs to market faster
Simplifying technology transfer to get drugs to market faster
Bio-Courier: a new delivery technology to increase the global accessibility of RNA therapeutics
Bio-Courier: a new delivery technology to increase the global accessibility of RNA therapeutics
What’s in a partner? The essential facets of a strong biopharma collaboration
What’s in a partner? The essential facets of a strong biopharma collaboration